Eric Patzer
Fondatore presso ARIDIS PHARMACEUTICALS, INC.
Patrimonio netto: 54 845 $ in data 31/05/2024
Profilo
Eric J.
Patzer is the founder of Aridis Pharmaceuticals, Inc. (founded in 2003) and holds the title of Executive Chairman.
He is currently a Director at FluGen, Inc. and Shenzhen Arimab Biopharmaceuticals Co., Ltd.
Eric's former positions include Vice President-Development at Genentech, Inc. (1981-1996), MedImmune Vaccines, Inc. (1996-2002), and Aviron, Inc. (Pennsylvania) (1996-2002).
He obtained a doctorate degree from the University of Virginia and an undergraduate degree from The Pennsylvania State University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 24/06/2024 | 884 600 ( 1.98% ) | 54 845 $ | 31/05/2024 |
Posizioni attive di Eric Patzer
| Società | Posizione | Inizio |
|---|---|---|
| ARIDIS PHARMACEUTICALS, INC. | Fondatore | 01/01/2003 |
FluGen, Inc.
 FluGen, Inc. Pharmaceuticals: MajorHealth Technology Flugen, Inc. develops and produces influenza vaccines. Its products include a live attenuated vaccine candidate, a cell-line technology that provides vaccine production efficiency and capacity, and a novel, vaccine-loaded intradermal delivery technology. The company was founded by Yoshihiro Kawaoka, Gabriele Neumann and Paul Radspinner in 2007 and is headquartered in Madison, WI. | Direttore/Membro del Consiglio | - |
| Shenzhen Arimab Biopharmaceuticals Co., Ltd. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Eric Patzer
| Società | Posizione | Fine |
|---|---|---|
MedImmune Vaccines, Inc.
 MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company was founded on April 15, 1992 and is headquartered in Mountain View, CA. | Corporate Officer/Principal | 01/01/2002 |
| Aviron, Inc. (Pennsylvania) | Corporate Officer/Principal | 01/01/2002 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/1996 |
Formazione di Eric Patzer
| University of Virginia | Doctorate Degree |
| The Pennsylvania State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ARIDIS PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company was founded on April 15, 1992 and is headquartered in Mountain View, CA. | Health Technology |
FluGen, Inc.
FluGen, Inc. Pharmaceuticals: MajorHealth Technology Flugen, Inc. develops and produces influenza vaccines. Its products include a live attenuated vaccine candidate, a cell-line technology that provides vaccine production efficiency and capacity, and a novel, vaccine-loaded intradermal delivery technology. The company was founded by Yoshihiro Kawaoka, Gabriele Neumann and Paul Radspinner in 2007 and is headquartered in Madison, WI. | Health Technology |
| Aviron, Inc. (Pennsylvania) | |
| Shenzhen Arimab Biopharmaceuticals Co., Ltd. |
- Borsa valori
- Insiders
- Eric Patzer
